about
Oncogenic function and early detection potential of miRNA-10b in oral cancer as identified by microRNA profiling.Pre-treatment levels of C-reactive protein and squamous cell carcinoma antigen for predicting the aggressiveness of pharyngolaryngeal carcinoma.Postoperative concomitant chemoradiotherapy improved treatment outcomes of patients with oral cavity cancer with multiple-node metastases but no other major risk factors.GP96 is over-expressed in oral cavity cancer and is a poor prognostic indicator for patients receiving radiotherapyClinical Outcomes of Patients with Resected Oral Cavity Cancer and Simultaneous Second Primary Malignancies.Pretreatment Dynamic Contrast-Enhanced MRI Improves Prediction of Early Distant Metastases in Patients With Nasopharyngeal Carcinoma.An Ultra-Deep Targeted Sequencing Gene Panel Improves the Prognostic Stratification of Patients With Advanced Oral Cavity Squamous Cell Carcinoma.Adding concurrent chemotherapy to postoperative radiotherapy improves locoregional control but Not overall survival in patients with salivary gland adenoid cystic carcinoma-a propensity score matched study.Incidence and Outcomes of Patients With Oral Cavity Squamous Cell Carcinoma and Fourth Primary Tumors: A Long-term Follow-up Study in a Betel Quid Chewing Endemic AreaPreoperative SCC Antigen, CRP Serum Levels, and Lymph Node Density in Oral Squamous Cell Carcinoma.Efficacy of Traditional Chinese Medicine in Xerostomia and Quality of Life during Radiotherapy for Head and Neck Cancer: A Prospective Pilot Study.Human Papillomavirus Infections are Common and Predict Mortality in a Retrospective Cohort Study of Taiwanese Patients With Oral Cavity Cancer.Changes and predictors of radiation-induced oral mucositis in patients with oral cavity cancer during active treatment.Proteomics of the radioresistant phenotype in head-and-neck cancer: Gp96 as a novel prediction marker and sensitizing target for radiotherapy.Induction chemotherapy with dose-modified docetaxel, cisplatin, and 5-fluorouracil in Asian patients with borderline resectable or unresectable head and neck cancer.Dynamic contrast-enhanced MRI, diffusion-weighted MRI and 18F-FDG PET/CT for the prediction of survival in oropharyngeal or hypopharyngeal squamous cell carcinoma treated with chemoradiation.Human papillomavirus 16/18 E7 viral loads predict distant metastasis in oral cavity squamous cell carcinoma.Pretreatment (18)F-FDG PET standardized uptake value of primary tumor and neck lymph nodes as a predictor of distant metastasis for patients with nasopharyngeal carcinoma.Outcome analyses of unusual site neck recurrence in oral cavity cancer.Hypothyroidism after radiotherapy for nasopharyngeal cancer patients.Prediction for distant failure in patients with stage M0 nasopharyngeal carcinoma: the role of standardized uptake value.Neck dissection field and lymph node density predict prognosis in patients with oral cavity cancer and pathological node metastases treated with adjuvant therapy.The effectiveness of a saline mouth rinse regimen and education programme on radiation-induced oral mucositis and quality of life in oral cavity cancer patients: A randomised controlled trial.Unmet supportive care needs and characteristics of family caregivers of patients with oral cancer after surgery.Supportive care needs in newly diagnosed oral cavity cancer patients receiving radiation therapy.Concurrent chemoradiotherapy using cisplatin, tegafur, and leucovorin for advanced squamous cell carcinoma of the hypopharynx and oropharynx.Pre-radiotherapy PSA level as a predictor for biochemical control in prostate cancer patients receiving radiotherapy after radical prostatectomy.Pretreatment T3-4 stage is an adverse prognostic factor in patients with esophageal squamous cell carcinoma who achieve pathological complete response following preoperative chemoradiotherapy.Increasing rates of low-risk human papillomavirus infections in patients with oral cavity squamous cell carcinoma: association with clinical outcomes.Positive clinical impact of an additional PET/CT scan before adjuvant radiotherapy or concurrent chemoradiotherapy in patients with advanced oral cavity squamous cell carcinoma.PET/CT and 3-T whole-body MRI in the detection of malignancy in treated oropharyngeal and hypopharyngeal carcinoma.Staging of untreated nasopharyngeal carcinoma with PET/CT: comparison with conventional imaging work-up.Combined-modality treatment for advanced oral tongue squamous cell carcinoma18F-FDG-PET for evaluation of the response to concurrent chemoradiation therapy with intensity-modulated radiation technique for Stage T4 nasopharyngeal carcinomaNeck treatment of patients with early stage oral tongue cancer: comparison between observation, supraomohyoid dissection, and extended dissectionHigh-dose-rate brachytherapy plus external beam radiotherapy for T1 to T3 prostate cancer: an experience in TaiwanTreatment outcome of combined modalities for buccal cancers: unilateral or bilateral neck radiation?Identification of a high-risk group among patients with oral cavity squamous cell carcinoma and pT1-2N0 diseaseOutcome analysis of patients with pN2 oral cavity cancerPET and PET/CT of the neck lymph nodes improves risk prediction in patients with squamous cell carcinoma of the oral cavity
P50
Q34253117-3E4C3F0B-5904-4582-BDF7-CE475FFA6261Q34576411-7DA9A1A3-FEF3-44C1-BBD3-2DB0563B9645Q35105893-F26CCF75-88E4-470C-87B9-81205EAAE5DDQ35544146-B306C455-4DA8-44F0-803A-CEA434679E0BQ35763266-00BFC84C-73B7-4AE3-9495-DB5A7E84F9D8Q36580841-AA3E6184-D37D-4E3E-B827-89F41B5B9F2AQ36653556-77538069-DBCE-46D0-BF6B-4EA0CAC596CAQ36714995-56B26D72-3271-4B16-84D8-F0E830BED4D7Q37205294-95F027CE-2C0D-4A0A-B5C9-5E9EE086AF47Q37206581-FE9CB2DB-B7D3-44E7-AB86-90C064505D99Q37232359-89F5A912-E8BE-4673-B539-B4A53A6963F7Q37328581-18B5C650-EEDA-45AE-B10D-40AE7A46122DQ39059471-130B573E-F73F-407D-A1CB-E80E6EECA8BCQ39682649-095C3C47-E816-4799-8879-41A3D4342F48Q40692267-9CAE0566-B73D-4CC2-AB85-B50A5B0422EFQ40890024-0FC6DE81-50DF-4C07-8448-7C47062053F4Q42201694-2CBF3563-7231-4C3F-BE56-9860DC21533FQ44419501-80DC0C4F-C93B-4FFA-82A1-48F0B5ED205EQ45905373-094C36FA-240E-4631-BAC1-17B0AED1C8E0Q45930491-FA65F727-6F3F-4445-8D50-5F9EF256E59BQ46590012-1C885113-D92D-4DB4-B887-C524A54B149DQ46656327-68B529C8-732E-4632-9C2F-983B51BC08D9Q47189331-07414FA7-C62C-4993-B254-FA1588FA7800Q48100818-CB04A644-953B-4AFF-B504-4174C71C0458Q48424331-EF2E81FD-6FD9-46C4-B0B6-F95929CCDB23Q50354993-BB81854F-C0FB-416F-94E3-63D918EB035BQ51019458-C2D20C31-B2AB-425E-996D-A617F872FB77Q51654012-656CDE00-18AC-4DD0-AC6D-2E84CB9E4BEAQ51874707-918E988C-DED0-4C28-9A57-608AA11A461EQ53034414-37C271B6-CF11-4B64-ACD4-C34F0F9ECC1EQ53243977-7DEEEAFD-8729-4ECB-8A69-274A2B98278FQ53398926-05418D83-C677-441F-AAA3-9F1FE4511FCAQ79608304-15D71ADC-3CA1-482E-AA84-6F741B81F79AQ79972955-388832D7-5BD0-40D7-A67E-898D795BF95EQ80623640-32B9B3C1-D02C-4FEB-AD68-9E385713D118Q80682562-F0009E30-A0CE-471B-9B15-DC9CCB7A8485Q80976351-477CB87D-99E4-48B3-B949-87BF42F27C73Q82448292-D5C2C9B1-3658-43B0-BAC5-2691528EEDE3Q82798589-1746BE59-D141-4216-9105-6F9B58DC1D78Q83306142-4BEC357A-60D0-40F4-A326-7A917D9EAD9A
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Kang-Hsing Fan
@ast
Kang-Hsing Fan
@en
Kang-Hsing Fan
@es
Kang-Hsing Fan
@nl
Kang-Hsing Fan
@sl
type
label
Kang-Hsing Fan
@ast
Kang-Hsing Fan
@en
Kang-Hsing Fan
@es
Kang-Hsing Fan
@nl
Kang-Hsing Fan
@sl
prefLabel
Kang-Hsing Fan
@ast
Kang-Hsing Fan
@en
Kang-Hsing Fan
@es
Kang-Hsing Fan
@nl
Kang-Hsing Fan
@sl
P106
P1153
35326598600
P31
P496
0000-0002-0910-7803